SHPH Shuttle Pharmaceuticals Holdings, Inc. - common stock
$3.69
가격 · 8월 24, 2026
기준 재무 정보 5월 15, 2026
SHPH 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$3.69
시가총액
$7M
P/E (TTM)
-0.5
EPS (TTM)
$-7.16
매출 (TTM)
—
배당 수익률
—
ROE
-400.1%
부채/자본
—
52주 범위
$0 – $6
SHPH 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
—
EPS
$-7.16
2022-12-31
→
2025-12-31
잉여현금흐름
—
2023-12-31
→
2023-12-31
마진
—
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
SHPH
동종업계 중앙값
P/E (TTM)
-0.5
0.1
P/B
3.3
4.4
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
SHPH
동종업계 중앙값
ROA
-180.6%
-69.9%
ROE
-400.1%
-290.9%
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
SHPH
동종업계 중앙값
Current Ratio (유동비율)
0.1
2.4
Quick Ratio (당좌 비율)
0.0
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
SHPH
동종업계 중앙값
Revenue YoY (매출 YoY)
0.00%
—
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
SHPH
동종업계 중앙값
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| SHPH | $4M | -0.3 | 0.00% | — | -400.1% | — |
| ONCO | $2M | -0.1 | -67.7% | -1721.0% | -129.5% | 77.6% |
| ADTX | $343.6K | -0.0 | -97.6% | -1349028.2% | -1183.4% | 8.4% |
| DCOY | — | -0.0 | — | — | — | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 13
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $4M | $4M | $4M | $1M | $1M | |
| SG&A Expense | $6M | $1M | $1M | $473.7K | $36.5K | |
| Operating Expenses | $12M | $8M | $6M | $2M | $2M | |
| Operating Income | $-12M | $-8M | $-6M | $-2M | $-2M | |
| Interest Income | $1.1K | $38.1K | $79.1K | · | · | |
| Other Non-op | $195.2K | $-1M | $-700.3K | $-3M | $590.9K | |
| Pretax Income | · | · | $-7M | $-5M | $-1M | |
| Net Income | $-12M | $-9M | $-7M | $-5M | $-1M | |
| EPS (Basic) | $-7.16 | $-79.65 | $-3.53 | $-5.04 | $-0.12 | |
| EPS (Diluted) | $-7.16 | $-82.60 | $-3.53 | $-5.04 | · | |
| Shares (Basic) | 1,637,926 | 114,807 | 1,866,275 | 1,337,742 | 9,301,750 | |
| Shares (Diluted) | 1,637,926 | 115,493 | 1,866,275 | 1,337,742 | · | |
| EBITDA | $-12M | $-8M | $-6M | $-3M | · |
대차대조표 22
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $334.0K | $2M | $3M | $8M | $504.7K | |
| Short-term Investments | · | · | $3M | · | · | |
| Prepaid Expense | $168.9K | $290.8K | $114.5K | $161.1K | $4.9K | |
| Current Assets | $502.9K | $2M | $6M | $9M | $509.6K | |
| PP&E (Net) | $17.3K | $19.4K | $24.8K | $12.6K | $18.6K | |
| PP&E (Gross) | · | · | · | $127.5K | $127.5K | |
| Accum. Depreciation | · | · | $121.7K | $114.9K | $108.9K | |
| Intangibles | $10M | · | · | · | · | |
| Other Non-current Assets | · | · | · | $6.5K | · | |
| Total Assets | $10M | $3M | $6M | $9M | $651.6K | |
| Accounts Payable | $1M | $596.6K | · | · | · | |
| Short-term Debt | · | $190.3K | · | $685.5K | · | |
| Current Liabilities | $8M | $2M | $1M | $975.7K | $2M | |
| Capital Leases | $155.0K | $238.1K | $304.1K | · | $62.4K | |
| Total Liabilities | $8M | $2M | $2M | $975.7K | $2M | |
| Long-term Debt | · | · | · | · | $91.0K | |
| Common Stock | $20 | $2 | $20 | $17 | $93 | |
| Paid-in Capital | $49M | $35M | $29M | $27M | $12M | |
| Retained Earnings | $-46M | $-35M | $-25M | $-19M | $-14M | |
| Stockholders' Equity | $2M | $709.2K | $4M | $8M | $-2M | |
| Liabilities + Equity | $10M | $3M | $6M | $9M | $651.6K | |
| Shares Outstanding | 2,023,615 | 163,093 | 2,008,689 | 1,700,414 | 9,312,152 |
현금 흐름 12
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| D&A | $290.1K | $5.5K | · | · | · | |
| Stock-based Comp | $933.0K | $259.7K | $182.0K | $237.5K | $910.1K | |
| Amort. of Intangibles | $288.1K | · | · | · | · | |
| Operating Cash Flow | $-9M | $-7M | $-6M | $-3M | $-300.3K | |
| CapEx | · | · | $19.0K | · | · | |
| Investing Cash Flow | $-3M | $3M | $-3M | · | · | |
| Net Debt Issued | · | $-59.7K | · | · | · | |
| Stock Issued | · | $4M | · | $10M | · | |
| Net Stock Activity | · | $4M | · | $10M | · | |
| Financing Cash Flow | $11M | $4M | $3M | $11M | $687.9K | |
| Net Change in Cash | $-2M | $-656.3K | $-6M | $8M | $387.6K | |
| Free Cash Flow | · | · | $-6M | · | · |
수익성 6
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Margin | · | -7696.2% | -11148.2% | · | · | |
| Net Margin | · | -9144.8% | -12473.2% | · | · | |
| Pretax Margin | · | · | -12473.2% | · | · | |
| EBITDA Margin | · | -7696.2% | -11148.2% | · | · | |
| ROA | -180.6% | -216.2% | · | -65.1% | · | |
| ROE | -400.1% | 3017.0% | · | -37.7% | · |
유동성 및 지급능력 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 0.1 | 1.4 | · | 8.8 | · | |
| Quick Ratio | 0.0 | 1.3 | · | 8.6 | · |
효율성 1
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | · | · |
성장률 1
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | · | 0.00% | · | · | · |
가치 평가 (TTM) 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-12M | $-9M | $-7M | $-5M | · | |
| Market Cap | $4M | $88M | · | $5.33B | · | |
| P/E | -0.3 | -0.3 | -25.8 | -77.8 | · | |
| P/B | 1.6 | 123.4 | · | 694.5 | · | |
| P / Tangible Book | · | 123.4 | 360.6 | 694.5 | · | |
| P / Cash Flow | -0.4 | -11.9 | · | -1967.4 | · | |
| Earnings Yield | -397.8% | -384.6% | -3.9% | -1.3% | · |
손익계산서 14
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $267.2K | $511.9K | $943.5K | $1M | $2M | $986.4K | $1M | $645.7K | $586.1K | $710.5K | $1M | $839.7K | $921.8K | $-1.4K | $669.0K | $83.9K | |
| SG&A Expense | $1M | $2M | $886.1K | $2M | $596.9K | $429.1K | $329.0K | $310.0K | $324.6K | $316.7K | $265.6K | $209.3K | $255.4K | $369.0K | $81.9K | $9.1K | |
| Operating Expenses | $2M | $3M | $2M | $4M | $3M | $2M | $3M | $1M | $1M | $1M | $2M | $1M | $2M | $530.3K | $821.5K | $353.6K | |
| Operating Income | $-2M | $-3M | $-2M | $-4M | $-3M | $-2M | $-3M | $-1M | $-1M | $-1M | $-2M | $-1M | $-2M | $-530.3K | $-821.5K | $-353.6K | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | $623.5K | · | · | · | · | · | |
| Interest Income | $209 | $523 | $486 | $81 | · | $3 | $2.5K | $14.2K | $21.5K | $22.4K | $20.8K | $19.3K | $16.7K | · | · | · | |
| Other Non-op | $64.4K | $173.3K | $-80.4K | $203.9K | $-101.8K | $178.7K | $-732.5K | $-548.6K | $-346.2K | $-357.7K | $-193.6K | $-718.7K | $569.7K | $-2M | $-177.0K | $-243.6K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $-2M | · | $-975.1K | $-3M | $-998.4K | · | |
| Net Income | $-2M | $-3M | $-2M | $-4M | $-3M | $-2M | $-4M | $-2M | $-2M | $-2M | $-2M | $-2M | $-975.1K | $-3M | $-998.4K | $-597.3K | |
| EPS (Basic) | $-0.43 | $-2.52 | $-1.05 | $-3.29 | $-7.60 | $-14.87 | $-39.83 | $-24.12 | $-0.83 | $-0.82 | $-0.91 | $-1.23 | $-0.57 | $-4.81 | $-0.10 | $-0.06 | |
| EPS (Diluted) | $-0.43 | $-2.52 | $-1.05 | $-3.29 | $-7.60 | $-17.82 | $-39.83 | $-24.12 | $-0.83 | $-0.82 | $-0.91 | $-1.23 | $-0.57 | $-4.81 | $-0.10 | $-0.06 | |
| Shares (Basic) | 5,031,569 | -11,770,693 | 2,233,650 | 1,126,054 | 401,957 | -2,140,139 | 95,004 | 84,197 | 2,075,745 | -3,588,317 | 1,969,904 | 1,780,171 | 1,704,517 | -27,452,398 | 10,164,979 | 9,312,991 | |
| Shares (Diluted) | 5,031,569 | -11,770,693 | 2,233,650 | 1,126,054 | 401,957 | -2,139,453 | 95,004 | 84,197 | 2,075,745 | -3,588,317 | 1,969,904 | 1,780,171 | 1,704,517 | · | · | 9,312,991 | |
| EBITDA | $-2M | · | $-2M | $-4M | $-3M | · | $-3M | $-1M | $-1M | · | $-2M | $-1M | $-2M | · | $-821.5K | · |
대차대조표 24
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1M | $334.0K | $2M | $5M | $5M | $2M | $156.7K | $695.6K | $1M | $3M | $4M | $5M | $7M | $8M | $9M | · | |
| Short-term Investments | · | · | · | · | · | · | · | $2M | $3M | $3M | $3M | $3M | $3M | · | · | · | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $6.0K | · | |
| Prepaid Expense | $1M | $168.9K | $1M | $374.2K | $446.8K | $290.8K | $103.0K | $139.5K | $129.6K | $114.5K | $170.1K | $78.9K | $203.8K | $161.1K | $163.1K | · | |
| Other Current Assets | · | · | · | · | · | · | · | · | $81.5K | · | $6.5K | $6.5K | · | · | · | · | |
| Current Assets | $2M | $502.9K | $3M | $5M | $5M | $2M | $361.4K | $2M | $4M | $6M | $7M | $8M | $10M | $9M | $9M | · | |
| PP&E (Net) | $16.3K | $17.3K | $18.3K | $19.3K | $18.4K | $19.4K | $21.2K | $22.0K | $22.9K | $24.8K | $26.8K | $9.6K | $11.1K | $12.6K | $14.1K | · | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | $127.5K | · | $127.5K | · | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | $116.4K | $114.9K | $113.4K | · | |
| Intangibles | $9M | $10M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | · | · | $6.5K | · | · | |
| Total Assets | $12M | $10M | $4M | $6M | $5M | $3M | $673.6K | $3M | $5M | $6M | $7M | $9M | $10M | $9M | $9M | · | |
| Accounts Payable | $2M | $1M | $1M | $1M | $896.9K | $596.6K | · | · | · | · | · | · | · | · | · | · | |
| Short-term Debt | · | · | · | · | · | $190.3K | · | · | · | · | · | · | $139.2K | · | · | · | |
| Current Liabilities | $8M | $8M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $810.4K | $493.7K | $1M | $975.7K | $970.5K | · | |
| Capital Leases | $134.1K | $155.0K | $175.3K | $195.2K | $220.1K | $238.1K | $255.6K | $267.0K | $288.6K | $304.1K | $308.4K | $329.8K | $751.7K | · | $6.7K | · | |
| Total Liabilities | $8M | $8M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $4M | $975.7K | $977.1K | · | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | $139.2K | · | · | · | |
| Common Stock | $57 | $20 | $13 | $11 | $63 | $2 | $29 | $21 | $21 | $20 | $160 | $155 | $137 | $17 | $136 | · | |
| Paid-in Capital | $52M | $49M | $45M | $45M | $41M | $35M | $32M | $30M | $30M | $29M | $19M | $19M | $17M | $27M | · | · | |
| Retained Earnings | $-48M | $-46M | $-44M | $-41M | $-38M | $-35M | $-33M | $-29M | $-27M | $-25M | $-14M | $-12M | $-10M | $-19M | $-8M | · | |
| Stockholders' Equity | $3M | $2M | $1M | $4M | $3M | $709.2K | $-1M | $801.4K | $3M | $4M | $6M | $7M | $7M | $8M | $8M | · | |
| Liabilities + Equity | $12M | $10M | $4M | $6M | $5M | $3M | $673.6K | $3M | $5M | $6M | $7M | $9M | $10M | $9M | $9M | · | |
| Shares Outstanding | 5,551,290 | 2,023,615 | 1,235,507 | 1,070,773 | 6,382,694 | 163,093 | 2,946,099 | 2,106,233 | 2,102,511 | 2,008,689 | 15,999,125 | 15,482,038 | 13,654,127 | 1,700,414 | 13,586,393 | · |
현금 흐름 12
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $633.3K | · | · | · | $1.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $35.0K | $214.8K | $134.3K | $46.9K | $537.0K | $31.9K | $45.3K | $71.2K | $111.4K | $86.5K | $37.6K | $49.5K | $8.3K | $-119.2K | $23.7K | $166.5K | |
| Amort. of Intangibles | $632.3K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-2M | $-973.0K | $-3M | $-3M | $-3M | $-3M | $-2M | $-1M | $-1M | $-1M | $-2M | $-2M | $-1M | $-635.8K | $-1M | $-355.4K | |
| CapEx | · | · | · | · | · | · | · | · | · | $0 | · | · | · | · | · | · | |
| Investing Cash Flow | $-36.0K | · | · | · | · | $0 | $2M | $1M | $101.3K | $87.0K | $-25.9K | $62.8K | $-3M | · | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | $600.0K | · | · | · | · | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $600.0K | · | · | · | · | · | · | · | |
| Stock Issued | $3M | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $3M | · | · | · | $5M | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $3M | $2M | $-96.4K | $4M | $5M | $4M | $-196.8K | $-461.7K | $-40.0K | $-334.4K | $0 | $-139.2K | $3M | $-67.4K | $10M | $0 | |
| Net Change in Cash | $755.9K | $-2M | $-3M | $305.1K | $3M | $2M | $-538.9K | $-703.0K | $-1M | $-1M | $-2M | $-2M | $-1M | $-703.2K | $9M | $-355.4K |
수익성 6
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | -10144.7% | · | · | · | -11985.3% | · | · | · | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | · | -7565.3% | · | · | · | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | · | -7565.3% | · | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | · | -10144.7% | · | · | · | -11985.3% | · | · | · | |
| ROA | -25.1% | · | -111.3% | -89.1% | -60.7% | · | -94.0% | -34.9% | · | · | -21.4% | -49.4% | -18.7% | · | -21.3% | · | |
| ROE | -64.9% | · | -5958.8% | -168.2% | -101.0% | · | -176.2% | -52.5% | · | · | -25.6% | -63.0% | -28.2% | · | -23.8% | · |
유동성 및 지급능력 3
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.3 | · | 1.7 | 3.1 | 2.8 | · | 0.2 | 1.8 | 3.0 | · | 8.6 | 17.1 | 7.5 | · | 9.6 | · | |
| Quick Ratio | 0.1 | · | 1.1 | 2.8 | 2.5 | · | 0.1 | 1.7 | 2.8 | · | 8.4 | 16.9 | 7.3 | · | 9.4 | · | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | · | · |
효율성 1
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | 0.0 | · | · | · | 0.0 | · | · | · |
가치 평가 (TTM) 9
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-11M | · | $-13M | $-13M | $-11M | · | $-9M | $-8M | $-7M | · | $-6M | $-5M | $-3M | · | $-2M | · | |
| Market Cap | $4M | · | $4M | $4M | $62M | · | $98M | $168M | $171M | · | $1.95B | $3.56B | $3.63B | · | $12.47B | · | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | $3.62B | · | · | · | |
| P/E | -0.1 | · | -0.1 | -0.1 | -0.1 | · | -0.5 | -3.0 | -22.9 | · | -43.4 | -117.3 | · | · | · | · | |
| P/B | 1.1 | · | 3.1 | 1.1 | 18.9 | · | -74.5 | 210.2 | 61.8 | · | 347.9 | 513.4 | 525.9 | · | 1483.9 | · | |
| P / Tangible Book | · | · | 3.1 | 1.1 | 18.9 | · | · | 210.2 | 61.8 | · | 347.9 | 513.4 | 525.9 | · | 1483.9 | · | |
| P / Cash Flow | -1.6 | · | · | · | -24.6 | · | · | · | -137.8 | · | · | · | -2714.5 | · | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | · | -2344.7 | · | · | · | |
| Earnings Yield | -1821.8% | · | -1252.7% | -1793.9% | -669.2% | · | -197.6% | -33.9% | -4.4% | · | -2.3% | -0.85% | · | · | · | · |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 영업이익률 % | — | -7696.2% | -11148.2% | — | — |
| 순이익 | $-12M | $-9M | $-7M | $-5M | $-1M |
| 희석 EPS | $-7.16 | $-82.60 | $-3.53 | $-5.04 | — |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 유동비율 | 0.1 | 1.4 | — | 8.8 | — |
| 당좌 비율 | 0.0 | 1.3 | — | 8.6 | — |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | — | — | $-6M | — | — |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F)
기관 활동 — Q1 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 2 (-2 이전 분기 대비) | 3 (+2 이전 분기 대비) | 3 (+1 이전 분기 대비) | 0 (-1 이전 분기 대비) | +51K |
Q4 2025 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
회사 내부자 11 명의 내부자 · 5 임원 · 5 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Anatoly Dritschilo | CEO and Chairman | 2023년 8월 14일 G | 2,100,000 | 0 | 0 | $0 |
| Hoek Michael Vander | Chief Financial Officer | 2024년 3월 8일 A | 103,852 | 0 | 0 | $0 |
| Peter Dritschilo | President and COO | 2022년 12월 29일 S | 6,560 | 0 | 0 | $0 |
| Mira Jung | Chief Scientific Officer | 2024년 5월 1일 A | 135,715 | 0 | 0 | $0 |
| Tyvin Rich | Chief Medical Officer | 2022년 12월 29일 S | 2,429 | 0 | 0 | $0 |
| Bette Jacobs | 이사 | 2023년 12월 13일 S | 27,064 | 0 | 0 | $0 |
| Milton Brown | 이사 | 2023년 12월 13일 S | 1,094,610 | 0 | 0 | $0 |
| Steven M Richards | 이사 | 2022년 12월 29일 S | 1,707 | 0 | 0 | $0 |
| Chris Senanayake | 이사 | 2022년 12월 29일 S | 2,791 | 0 | 0 | $0 |
| HRT FINANCIAL LP | 10% 소유주 | 2026년 7월 14일 S | 0 | 6 | 5 | $-323,066 |
| William Adkins | — | 2022년 9월 2일 J | 184,071 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당